Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Autobio Diagnostics is a leading clinical diagnostics company headquartered in Zhengzhou, China, specializing in the research, development, and manufacturing of in-vitro diagnostic (IVD) products. The company offers a comprehensive portfolio of laboratory instruments and reagents covering immunology, microbiology, biochemistry, and molecular diagnostics. Autobio is particularly recognized for its automated chemiluminescence immunoassay (CLIA) systems and its leadership in the Chinese IVD market. Founded in 1998, it has expanded its footprint globally, providing high-throughput testing solutions to hospitals and clinical laboratories. The company is publicly traded on the Shanghai Stock Exchange and continues to invest heavily in next-generation diagnostics, including mass spectrometry and automated laboratory workstations.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on AutoSearch.